Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review. Wan Y, Zeng F, Tan H, Lu Y, et al. Osteoporos Int 2022 Jan 21. pii: 10.1007/s00198-021-06268.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wan Y, Zeng F, Tan H, Lu Y, et al. Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review. Osteoporos Int 2022 Jan 21. pii: 10.1007/s00198-021-06268.
PMID: 35059777